Modulus, a cell therapy biotech incubated at the Allen Institute for AI, raises $3.5M by Charlotte Schubert on July 15, 2021July 20, 2021 at 1:49 pm Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2), announced $3.5 million in seed funding. The company combines laboratory research with machine… Read More